Treatment of hyperlipidemia with combined niacin–statin regimens
- 17 December 1998
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 82 (12) , 82U-84U
- https://doi.org/10.1016/s0002-9149(98)00955-2
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol LevelsJAMA, 1998
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Niacin revisited: Clinical observations on an important but underutilized drugThe American Journal of Medicine, 1991
- Beneficial Effects of Colestipol-Niacin on Coronary AtherosclerosisPublished by American Medical Association (AMA) ,1990
- Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein BNew England Journal of Medicine, 1990
- Reduction of Mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by Combined Treatment with Clofibrate and Nicotinic AcidActa Medica Scandinavica, 1988
- Myolysis and Acute Renal Failure in a Heart-Transplant Recipient Receiving LovastatinNew England Journal of Medicine, 1988
- Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacinJournal of the American College of Cardiology, 1986
- Clofibrate and Niacin in Coronary Heart DiseaseJAMA, 1975